4basebio (LON:4BB) Insider Hansjörg Plaggemars Purchases 1,000 Shares

4basebio PLC (LON:4BB) insider Hansjörg Plaggemars purchased 1,000 shares of the business’s stock in a transaction on Tuesday, February 10th. The stock was acquired at an average price of GBX 585 per share, with a total value of £5,850.

4basebio Stock Performance

Shares of 4BB stock opened at GBX 565 on Thursday. The firm has a market capitalization of £87.49 million, a price-to-earnings ratio of -5.71 and a beta of 1.09. 4basebio PLC has a one year low of GBX 520 and a one year high of GBX 1,220. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The company has a 50 day moving average price of GBX 606.24 and a 200 day moving average price of GBX 737.81.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.